homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

May 27, 2020

Prevencio

Kirkland-based Prevencio inked a deal with Seattle Children’s Research Institute to develop a blood test that diagnoses Kawasaki disease in children. Kawasaki disease may be triggered by COVID-19 and exhibits similar symptoms. Prevencio says it uses artificial intelligence, algorithms and multi-proteomic biomarkers for cardiovascular diagnostic and prognostic tests that are significantly more accurate than standard-of-care stress tests. There currently is no diagnostic test for Kawasaki disease, according to the company.




Email or user name:
Password:
 
Forgot password? Click here.